Laparoscopic optical coherence tomographic imaging of human ovarian cancer

Lida P. Hariri, Garret T. Bonnema, Kathy Schmidt, Kenneth D Hatch, Molly Brewer, Jennifer K Barton

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Ovarian cancer is the fourth leading cause of cancer-related death among women in the United States. If diagnosed at an early stage, the 5-year survival rate is 94%, but drops to 68% for regional disease and 29% for distant metastasis; only 19% of all cases are diagnosed at the early, localized stage. Optical coherence tomography is a recently emerging non-destructive imaging technology, achieving high axial resolutions (10-20 microns) at imaging depths up to 2 mm. Previously, we studied OCT imaging in normal and diseased human ovary ex vivo to determine the features OCT is capable of resolving. Changes in collagen were suggested with several of the images that correlated with changes in collagen seen in malignancy. Areas of necrosis and blood vessels were also visualized using OCT, indicative of an underlying tissue abnormality. We recently developed a custom side-firing laparoscopic OCT (LOCT) probe fabricated specifically for in vivo laparoscopic imaging. The LOCT probe consists of a 38 mm diameter handpiece terminated in an 280 mm long, 4.6 mm diameter tip for insertion into the laparoscopic trocar and is capable of obtaining up to 9.5 mm image lengths at 10 micron axial resolution. In this study, we utilize the LOCT probe to image one or both ovaries of 20 patients undergoing laparotomy or transabdominal endoscopy and oophorectomy to determine if OCT is capable of identifying and/or differentiating normal and neoplastic ovary. To date, we have laparoscopically imaged the ovaries of ten patients successfully with no known complications..

Original languageEnglish (US)
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume6851
DOIs
StatePublished - 2008
EventEndoscopic Microscopy III - San Jose, CA, United States
Duration: Jan 20 2008Jan 21 2008

Other

OtherEndoscopic Microscopy III
CountryUnited States
CitySan Jose, CA
Period1/20/081/21/08

Fingerprint

Imaging techniques
Collagen
Endoscopy
Optical tomography
Blood vessels
Tissue

Keywords

  • Laparoscocpy
  • Optical coherence tomography
  • Ovarian cancer

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Hariri, L. P., Bonnema, G. T., Schmidt, K., Hatch, K. D., Brewer, M., & Barton, J. K. (2008). Laparoscopic optical coherence tomographic imaging of human ovarian cancer. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 6851). [685107] https://doi.org/10.1117/12.760995

Laparoscopic optical coherence tomographic imaging of human ovarian cancer. / Hariri, Lida P.; Bonnema, Garret T.; Schmidt, Kathy; Hatch, Kenneth D; Brewer, Molly; Barton, Jennifer K.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 6851 2008. 685107.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Hariri, LP, Bonnema, GT, Schmidt, K, Hatch, KD, Brewer, M & Barton, JK 2008, Laparoscopic optical coherence tomographic imaging of human ovarian cancer. in Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 6851, 685107, Endoscopic Microscopy III, San Jose, CA, United States, 1/20/08. https://doi.org/10.1117/12.760995
Hariri LP, Bonnema GT, Schmidt K, Hatch KD, Brewer M, Barton JK. Laparoscopic optical coherence tomographic imaging of human ovarian cancer. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 6851. 2008. 685107 https://doi.org/10.1117/12.760995
Hariri, Lida P. ; Bonnema, Garret T. ; Schmidt, Kathy ; Hatch, Kenneth D ; Brewer, Molly ; Barton, Jennifer K. / Laparoscopic optical coherence tomographic imaging of human ovarian cancer. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 6851 2008.
@inproceedings{a170169c0e8c4ee793ef574cfe3bbb9a,
title = "Laparoscopic optical coherence tomographic imaging of human ovarian cancer",
abstract = "Ovarian cancer is the fourth leading cause of cancer-related death among women in the United States. If diagnosed at an early stage, the 5-year survival rate is 94{\%}, but drops to 68{\%} for regional disease and 29{\%} for distant metastasis; only 19{\%} of all cases are diagnosed at the early, localized stage. Optical coherence tomography is a recently emerging non-destructive imaging technology, achieving high axial resolutions (10-20 microns) at imaging depths up to 2 mm. Previously, we studied OCT imaging in normal and diseased human ovary ex vivo to determine the features OCT is capable of resolving. Changes in collagen were suggested with several of the images that correlated with changes in collagen seen in malignancy. Areas of necrosis and blood vessels were also visualized using OCT, indicative of an underlying tissue abnormality. We recently developed a custom side-firing laparoscopic OCT (LOCT) probe fabricated specifically for in vivo laparoscopic imaging. The LOCT probe consists of a 38 mm diameter handpiece terminated in an 280 mm long, 4.6 mm diameter tip for insertion into the laparoscopic trocar and is capable of obtaining up to 9.5 mm image lengths at 10 micron axial resolution. In this study, we utilize the LOCT probe to image one or both ovaries of 20 patients undergoing laparotomy or transabdominal endoscopy and oophorectomy to determine if OCT is capable of identifying and/or differentiating normal and neoplastic ovary. To date, we have laparoscopically imaged the ovaries of ten patients successfully with no known complications..",
keywords = "Laparoscocpy, Optical coherence tomography, Ovarian cancer",
author = "Hariri, {Lida P.} and Bonnema, {Garret T.} and Kathy Schmidt and Hatch, {Kenneth D} and Molly Brewer and Barton, {Jennifer K}",
year = "2008",
doi = "10.1117/12.760995",
language = "English (US)",
isbn = "9780819470263",
volume = "6851",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",

}

TY - GEN

T1 - Laparoscopic optical coherence tomographic imaging of human ovarian cancer

AU - Hariri, Lida P.

AU - Bonnema, Garret T.

AU - Schmidt, Kathy

AU - Hatch, Kenneth D

AU - Brewer, Molly

AU - Barton, Jennifer K

PY - 2008

Y1 - 2008

N2 - Ovarian cancer is the fourth leading cause of cancer-related death among women in the United States. If diagnosed at an early stage, the 5-year survival rate is 94%, but drops to 68% for regional disease and 29% for distant metastasis; only 19% of all cases are diagnosed at the early, localized stage. Optical coherence tomography is a recently emerging non-destructive imaging technology, achieving high axial resolutions (10-20 microns) at imaging depths up to 2 mm. Previously, we studied OCT imaging in normal and diseased human ovary ex vivo to determine the features OCT is capable of resolving. Changes in collagen were suggested with several of the images that correlated with changes in collagen seen in malignancy. Areas of necrosis and blood vessels were also visualized using OCT, indicative of an underlying tissue abnormality. We recently developed a custom side-firing laparoscopic OCT (LOCT) probe fabricated specifically for in vivo laparoscopic imaging. The LOCT probe consists of a 38 mm diameter handpiece terminated in an 280 mm long, 4.6 mm diameter tip for insertion into the laparoscopic trocar and is capable of obtaining up to 9.5 mm image lengths at 10 micron axial resolution. In this study, we utilize the LOCT probe to image one or both ovaries of 20 patients undergoing laparotomy or transabdominal endoscopy and oophorectomy to determine if OCT is capable of identifying and/or differentiating normal and neoplastic ovary. To date, we have laparoscopically imaged the ovaries of ten patients successfully with no known complications..

AB - Ovarian cancer is the fourth leading cause of cancer-related death among women in the United States. If diagnosed at an early stage, the 5-year survival rate is 94%, but drops to 68% for regional disease and 29% for distant metastasis; only 19% of all cases are diagnosed at the early, localized stage. Optical coherence tomography is a recently emerging non-destructive imaging technology, achieving high axial resolutions (10-20 microns) at imaging depths up to 2 mm. Previously, we studied OCT imaging in normal and diseased human ovary ex vivo to determine the features OCT is capable of resolving. Changes in collagen were suggested with several of the images that correlated with changes in collagen seen in malignancy. Areas of necrosis and blood vessels were also visualized using OCT, indicative of an underlying tissue abnormality. We recently developed a custom side-firing laparoscopic OCT (LOCT) probe fabricated specifically for in vivo laparoscopic imaging. The LOCT probe consists of a 38 mm diameter handpiece terminated in an 280 mm long, 4.6 mm diameter tip for insertion into the laparoscopic trocar and is capable of obtaining up to 9.5 mm image lengths at 10 micron axial resolution. In this study, we utilize the LOCT probe to image one or both ovaries of 20 patients undergoing laparotomy or transabdominal endoscopy and oophorectomy to determine if OCT is capable of identifying and/or differentiating normal and neoplastic ovary. To date, we have laparoscopically imaged the ovaries of ten patients successfully with no known complications..

KW - Laparoscocpy

KW - Optical coherence tomography

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=42149100052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149100052&partnerID=8YFLogxK

U2 - 10.1117/12.760995

DO - 10.1117/12.760995

M3 - Conference contribution

SN - 9780819470263

VL - 6851

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

ER -